ACE2 and viral infectious disease: These can be an indirect effect of proinflammatory agents triggered in response to the viral infection or due to the direct interaction of SARS-CoV-2 with angiotensin-converting enzyme 2 (ACE2), which is utilized as a cellular entry receptor.